Skip to main content
Equibles
OWLT logo

OWLT · Owlet, Inc.

Track OWLT — free

Use OWLT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about OWLT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$5.16 -0.04 (-0.77%) At close · Aug 26
Going-concern doubt — flagged May 11, 2026

Substantial doubt about the company's ability to continue as a going concern.

“the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements included in this quarterly report on Form 10-Q are issued.”
View the 10-Q filed May 11, 2026
Market Cap
$151.63M
Shares
29.22M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.16 Open$5.15 Day$4.93–5.28 52W close$4.44–16.52 Avg vol 30d195K Short int502K · 1.7% float · 2.0d Short vol57% Last earningsAug 11, 2026 DataJul 2023–Aug 2026 Filing10-Q · Aug 14

Raw chart and full-history price indicators begin at the captured split on Jul 10, 2023; bars on opposite sides are not compared.

Up next

Next earnings call
Nov 16, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 14, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15.2 · calm Equity put/call 0.64
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −39%
      below
      Price vs 50-day avg −7%
      below
      RSI (14) 43
      neutral
      MACD trend Negative
      52-week position 6%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +2%
      trailing
      6-month return −56%
      trailing
      YTD return −68%
      this year
      Relative strength −69%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $6 › 200d $8 — 200d above 50d
      Institutional flow Distributing
      -12% holders QoQ · +11 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      1.72% of float · ▼ -2.7% MoM · 2.0 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Steady
      59 holders — mid 3-yr range
      Squeeze score 41
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +37%
      Y/Y
      Gross margin 51%
      expanding
      EPS growth −43%
      Y/Y
      Free cash flow $-11.1M
      Balance sheet $22.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 83%
      annualized · 1-yr
      Max drawdown −73%
      past year
      ATR 8.8%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Beat or met 2 of last 2
      Latest guidance · from the 8-K filed Aug 11, 2026
      Total Revenue · full year 2026 Maintained $118M – $122M
      May 7, 2026 $118M – $122M changed to Aug 11, 2026 $118M – $122M
      prior FY $106.16M midpoint +13.0% Y/Y
      Gross Margin · full year 2026 Initiated 53% – 55%
      Adjusted EBITDA · full year 2026 Non-GAAP Initiated $10.75M – $12.75M
      Prior guidance period ended · from the 8-K filed Mar 5, 2026
      Revenue · first quarter of 2026 $20M – $21M
      Gross margins · first quarter of 2026 50% – 52%
      Adjusted EBITDA · first quarter of 2026 $-2.5M – $-1.5M
      Guided vs delivered · last 2 settled
      Revenue full year 2025
      guided $103M – $106M
      $106.16M Beat +1.6%
      Revenue full year of 2022
      guided $69M – $74M
      $69.2M In line

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −39% Bearish
      Price vs 50-day avg
      −7% Bearish
      RSI (14)
      43 Neutral
      MACD trend
      Negative Bearish
      52-week position
      6% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $6 › 200d $8 — 200d above 50d
      Institutional flow Distributing
      -12% holders QoQ · +11 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Falling
      1.72% of float · ▼ -2.7% MoM · 2.0 days cover
      Volume signal Reversal watch
      High volume on a down day — possible exhaustion
      Institution breadth Steady
      59 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $4 Now $5 · 6% Range high $17
      vs 200-day avg -39% vs 50-day avg -7%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Non-GAAP adjusted net income (loss) non-GAAP $3.3M Six Months Ended June 30, 2026 —
      Non-GAAP adjusted net income (loss) per share non-GAAP $0.12 Six Months Ended June 30, 2026 —
      Subscription gross margin 68.4% Q2 2026 —
      Non-GAAP adjusted net loss non-GAAP -$2.4M Three Months Ended March 31, 2026 —
      Non-GAAP adjusted net loss per share non-GAAP -$0.09 Three Months Ended March 31, 2026 —
      paying subscribers 115,000 first quarter ended March 31, 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      OWLT
      Owlet, Inc.
      this stock
      		$151.63M -68.1% +37.1% — 1.7%
      ABT
      Abbott Laboratories
      		 $203.22B -8.9% +5.7% 32.7 1.2%
      SYK
      Stryker Corp
      		 $126.45B -6.2% +11.2% 34.2 1.8%
      MDT
      Medtronic plc
      		 $117.57B -4.2% +8.4% 24.6 1.1%
      BSX
      Boston Scientific Corp
      		 $72.26B -49.5% +12.5% 20.2 1.9%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      59
      % held
      58.5%
      Net QoQ
      -535.5K sh
      Top holder
      ECLIPSE OPERATIONS, LLC
      Held Float
      View
      Held by Funds
      Fund positions
      30
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      501.6K
      Days to cover
      2.0d
      Change
      -13.8K sh
      View
      Short Volume
      Short vol %
      57%
      As of
      Aug 26, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      217
      Value
      $1.2K
      As of
      Jul 22, 2026
      View
      Off-Exchange
      Off-exchange %
      43.6%
      Week of
      Jul 20, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $106.2M
      Net income (FY)
      $-38.8M
      EPS diluted
      $-2.27
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 14, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $19.1K
      Shares
      5.0K
      Filed
      May 16, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 11, 2026
      View
      Investor Relations
      Latest news
      Owlet Announces Second Quarter 20…
      Published
      Aug 11, 2026
      View

      Performance

      Raw-price comparisons begin at the captured split on Jul 10, 2023; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      OWLT -10.9% +2.2% -56.1% +0.4% -68.1%
      SPY -0.4% +5.0% +12.4% +2.6% +12.3%
      vs SPY -10.5% -2.8% -68.5% -2.2% -80.5%
      Key facts CIK 1816708 CUSIP 69120X206 13F (30d) 56 filings 54 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)